Paid Clinical Trials in Fort Wayne, IN

As of July 2026, 103 paid clinical trials are recruiting in Fort Wayne, Indiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

98 clinical trials

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

for Neoplasm, Colorectal

1 location in Fort Wayne

Sponsor: Joseph McCollom

Sex: All·Age: 18+

Code: NCT05014399·Recruiting·Listed Aug 2021

Apply to this trial

Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip

for GI Bleeding

Sites in Fort Wayne +1 more location

Sponsor: AdventHealth

Sex: All·Age: 18+

Code: NCT05852457·Recruiting·Listed May 2023

Apply to this trial

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for Aortic Stenosis

Sites in Fort Wayne, Elkhart +53 more locations

Sponsor: University of British Columbia

Sex: All·Age: All ages

Code: NCT04634240·Recruiting·Listed Nov 2020

Apply to this trial

HVLAT, Electric DN, Exercise Vs. Mobilization, STM, Exercise, TENS for Tension Type Headaches

for Tension-Type Headache

1 location in Fort Wayne

Sponsor: Alabama Physical Therapy & Acupuncture

Sex: All·Age: 18 - 65

Code: NCT04609709·Recruiting·Listed Oct 2020

Apply to this trial

Manual Therapy, Exercise and US Vs. Manual Therapy, Exercise and US for Medial Epicondylalgia

for Epicondylalgia

1 location in Fort Wayne

Sponsor: Alabama Physical Therapy & Acupuncture

Sex: All·Age: 18 - 60

Code: NCT04609735·Recruiting·Listed Oct 2020

Apply to this trial

Families of Youth with Developmental Disabilities: a Theory-Based Intervention

for Family Conflict

Sites in Fort Wayne & South Bend

Sponsor: University of Notre Dame

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT03495440·Recruiting·Listed Apr 2018

Apply to this trial

The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families

for Mental Health

Sites in Fort Wayne, Indianapolis & Notre Dame

Sponsor: University of Notre Dame

Sex: All·Age: 4+·Accepts healthy volunteers

Code: NCT04980794·Recruiting·Listed Jul 2021

Apply to this trial

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

for Stomatitis

Sites in Fort Wayne +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07357597·Phase 4·Recruiting·Listed Jan 2026

Apply to this trial

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for Epithelial Ovarian Cancer

Sites in Fort Wayne, Indianapolis +37 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07218809·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

for Breast Cancer

Sites in Fort Wayne +4 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07205822·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for Endometrial Cancer

Sites in Fort Wayne, Indianapolis +65 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for Untreated Follicular Lymphoma

Drug: Rituximab

Sites in Fort Wayne +52 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06549595·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Fort Wayne +62 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

for Breast Cancer, Early Breast Cancer

Drug: Camizestrant

Sites in Fort Wayne +103 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05952557·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for Neoplasms, Head and Neck

Drug: Dostarlimab

Sites in Fort Wayne +30 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06256588·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

for Neoplasms

Sites in Fort Wayne +14 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06551142·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Fort Wayne +27 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06350097·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial